Cite

HARVARD Citation

    Armstrong, D. et al. (2006). Bone marker response in chronic diffuse sclerosing osteomyelitis treated with intravenous ibandronate. Annals of the rheumatic diseases. 65 (7), pp. 976-977. [Online]. 
  
Back to record